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Introduction: Massachusetts established 17 new Medicaid accountable care
organizations (ACOs) and 24 affiliated Community Partners (CPs) in 2018 as part of a
large-scale healthcare reform effort to improve care value. The new ACOs will receive
$1.8 billion dollars in state and federal funding over 5 years through the Delivery System
Reform Incentive Program (DSRIP). The multi-faceted study described in this protocol
aims to address gaps in knowledge about Medicaid ACOs’ impact on healthcare
value by identifying barriers and facilitators to implementation and sustainment of the
DSRIP-funded programs.
Methods and analysis: The study’s four components are: (1) Document Review
to characterize the ACOs and CPs; (2) Semi-structured Key Informant Interviews (KII)
with ACO and CP leadership, state-level Medicaid administrators, and patients; (3) Site
visits with selected ACOs and CPs; and (4) Surveys of ACO clinical teams and CP
staff. The Consolidated Framework for Implementation Research’s (CFIR) serves as the
study’s conceptual framework; its versatile menu of constructs, arranged across five
domains (Intervention Characteristics, Inner Setting, Outer Setting, Characteristics of
Individuals, and Processes) guides identification of barriers and facilitators acrossmultiple
organizational contexts. For example, KII interview guides focus on understanding
how Inner and Outer Setting factors may impact implementation. Document Review
analysis includes extraction and synthesis of ACO-specific DSRIP-funded programs (i.e.,
Intervention Characteristics); KIIs and site visit data will be qualitatively analyzed using
thematic analytic techniques; surveys will be analyzed using descriptive statistics (e.g.,
counts, frequencies, means, and standard deviations).
Discussion: Understanding barriers and facilitators to implementing and sustaining
Medicaid ACOs with varied organizational structures will provide critical context for
understanding the overall impact of the Medicaid ACO experiment in Massachusetts.
Goff et al. Reducing Disparities Through Value-Based Care
It will also provide important insights for other states considering the ACO model for their
Medicaid programs.
Ethics and dissemination: IRB determinations were that the overall study did not
constitute human subjects research and that each phase of primary data collection
should be submitted for IRB review and approval. Study results will be disseminated
through traditional channels such as peer reviewed journals, through publicly available
reports on the mass.gov website; and directly to key stakeholders in ACO and
CP leadership.
Keywords: value-based care, accountable care organization, implementation, Medicaid, disparities
CONTRIBUTIONS TO THE LITERATURE
• This study will be one of the first to systematically identify
barriers and facilitators to implementing and sustaining
a large-scale systems transformation initiative across the
duration of the 5-year program.
• Understanding implementation barriers and facilitators will
provide important context for interpreting the overall impact
of the systems transformation initiative on quality and costs
of care.
• Findings of the study are expected to have utility for policy-
makers and health system leaders considering implementation
of innovative health care delivery models in the U.S.
and abroad.
INTRODUCTION
Global efforts to address the rising costs of healthcare while
maintaining or improving quality of care have increasingly
included implementation of accountable care organizations
(ACOs) (1–3). The value-based payment models used by ACOs
incentivize quality of care and cost reduction through payer-
provider partnerships in which financial risks are shared. The
ACO model aligns financial incentives with improvements in
care integration and coordination across health and social service
sectors (4), differing from fee-for-service payment models’
prioritization of volume and intensity of care. This important
shift in financial incentives prioritizes prevention and population
health, which has the potential to improve healthcare delivery
and clinical outcomes for patients at higher risk for experiencing
healthcare inequities and health disparities.
The majority of research on ACOs to date in the U.S. has
focused on changes in quality of care, costs, and patient outcomes
associated with Medicare and commercial ACO programs (5–
17) in the Medicare system, which insures patients age 65 year
of age or older. Identifying and understanding the barriers
and facilitators to implementing and sustaining the changes in
Abbreviations: ACO, accountable care organization; MA, Massachusetts; CP,
Community Partner; LTSS, long term services and supports; DSRIP, Delivery
System Reform Program; SWI, StateWide Investments; CFIR, Consolidated
Framework for Implementation Research; MD, Medical Doctor; DO, Doctor of
Osteopathy; NP, Nurse Practitioner; PA, Physician’s Assistant; LPN, Licensed
Practical Nurse; LICSW, Licensed Social Worker.
healthcare delivery encountered by ACOs from the early stages
of their inception is critical for interpreting the downstream
effects on health care value and patient outcomes. However, prior
studies of ACO implementation have focused onMedicare ACOs
or been limited to a narrow timeframe or scope (18–20) and
none to our knowledge have examined barriers and facilitators
to long-term sustainment over time.
The state of Massachusetts’s (MA) Medicaid program
(MassHealth) contracted with 17 new ACOs and 27 associated
Community Partner (CP) organizations in 2018 as part of a 5-
year experimental demonstration project, subsequently referred
to as the Demonstration. The CPs, an innovative feature of the
MA model, work with the ACOs to coordinate and manage
care for ACO patients with behavioral health diagnoses or for
those who need long-term services and supports (LTSS). This
study aims to identify barriers and facilitators to implementation
and sustainment of interventions funded by the Delivery System
Reform Incentive Payment (DSRIP) program across these new
Medicaid ACOs and CPs. The protocol for studying the MA
Medicaid ACO experiment’s effectiveness at improving quality
while maintaining or reducing costs will be reported elsewhere.
METHODS AND ANALYSIS
Overview
This study aims to determine the extent to which the
organizations that comprise the ACOs and CPs are able to
implement the system transformation initiative as intended
and to identify facilitators and barriers to implementation
and sustainment. The study has two primary aims: to use a
mixed-methods, developmental approach to identify issues with
implementation early in the ACO experiment so that adaptations
may be made if indicated (21) and to produce generalizable
knowledge for federal policy-makers and healthcare systems
seeking to transform how healthcare is delivered and supported
to vulnerable populations.
The study’s theoretical framework draws on the Consolidated
Framework for Implementation Research (CFIR) (22). CFIR
was chosen as the theoretical framework for the study
because its domains (Intervention Characteristics, Outer
Setting, Inner Setting, Characteristics of Individuals, and
Process of Implementation) and the constructs within the
domains are pertinent to studying the implementation and
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sustainment of complex interventions, such as healthcare
delivery transformation. CFIR is also an appropriate framework
for this study because its flexible structure is designed to be
used across multiple phases of a study, from design through
dissemination. Each of the five domains is explored in at least
one of the study’s four phases.
ACOs and the Delivery System Reform
Incentive Program (DSRIP)
Accountable care organizations (ACOs) are networks of doctors
and hospitals that share financial and medical responsibility
for providing coordinated care to patients in hopes of limiting
unnecessary spending, meaning they aim to increase the
value of the care provided (23). The Patient Protection and
Affordable Care Act of 2010 made provisions for Medicare,
which insures nearly all people age 65 or older in the U.S., to
implement ACOs in its program (24, 25). DSRIP funds “support
the restructuring of MassHealth’s delivery system to promote
integrated, coordinated care and hold providers accountable
for quality and total cost of care (26).” DSRIP funding in
MA is a one-time federal investment of $1.8 billion dollars
that phases down over the course of 5 years, after which the
programs are expected to be self-sustainable. DSRIP funds pay
for programs that support health care delivery transformation
in the ACOs and CPs; DSRIP funds also support the MA
Statewide Investment program (SWI), which funds activities
related to workforce development and retention, technical
assistance, enhanced diversionary behavioral health activities,
and increasing access for patients with disabilities or for whom
English is not the first language (26). Each ACO and CP
developed a unique plan to use the DSRIP funds that was tailored
to their implementation and sustainment needs and to meet the
needs of the patient population they serve (27). The activities
funded by the DSRIP program support the ACOs and CPs in
achieving the goal of increased value of the care delivered.
Methods
To achieve the study’s aim, implementation and sustainment
data will be collected in four-phases: (1) Document Review to
characterize ACOs and CPs; (2) Key Informant Interviews (KIIs)
with ACOs’ and CPs’ leadership as well as MassHealth patients in
two waves; (3) Site visits conducted with select ACOs and CPs;
and (4) Surveys of ACO clinical team members and CP staff. The
methods and the analytic plan for each phase are described in
detail below; the timeline and goals of each phase of the study are
outlined in Table 1. The Institutional Review Board (IRB) at the
research team’s institution requested to review the procedures for
each phase of data collection sequentially. To date, the IRB has
determined that Phases 1 and 2 do not constitute human subjects
research. Phases 3 and 4 will be submitted prior to beginning
these phases and IRB determinations followed.
Systematic Characterization of the MA ACOs and
CPs
The design of the Demonstration gave ACOs and the CPs
flexibility in determining their organizational structures and how
they plan to utilize DSRIP funding. Given this heterogeneity,
we will systematically characterize the organizational structures
TABLE 1 | Data sources and timeline.
Year 1–2 Year 3 Year 4 Year 5
Document review X X X X
State interviews X X
ACO, CP, and MCO interviews X X
Consumer interviews X X
Provider and staff survey X X
ACO and CP site visits X X
of each ACO and CP, patient population, budget for DSRIP
funds, and plans for implementing DSRIP-funded programs
in Phase 1. This will be achieved through extraction of
pertinent data from the Participation Plans submitted by each
ACO and CP prior to being approved to participate in the
Demonstration. The Participation Plans include ACOs’ and
CPs plans for their governing structures, a description of their
patient population, and plans for DSRIP implementation. The
Participation Plan data describes how each organization intends
to change healthcare delivery within their organization, such
as by using health information technology to address health-
related social needs and hiring community health workers to
support care coordination and management. Data elements
to be extracted were determined using the CFIR framework:
Intervention Characteristics (specific plans for use of DSRIP
funds); Outer Setting (population characteristics), and Inner
Setting (governance structures, partnerships/networks, and prior
experience with value-based care models). The extracted data will
be summarized in streamlined reports that provide systematic
categorization of the ACOS and CPs. The reports will be made
available to the research team members conducting the KIIs
(See section methods and analysis) to enable them to tailor
interview questions to pertinent aspects of each ACO’s or CP’s
unique organizational structure and plans for DSRIP spending
and implementation of DSRP-funded activities and programs.
Key Informant Interviews (KII)
Overview
Two waves of semi-structured in-depth interviews will be
conducted with representatives of four stakeholder groups:
(1) ACOs; (2) CPs; (3) MassHealth staff responsible for
administering the DSRIP program, and (4) MassHealth patients.
Sample sizes for each group are intended to strike a balance
between breadth and depth and to achieve theoretical saturation
(no new concepts emerging over three sequential interviews)
while minimizing respondent burden (Table 2). Interviews will
be conducted with each stakeholder group at interim and end-
points of the Demonstration; efforts will be made to interview
the same participants in each wave to reduce the chance that any
changes reported may be more reflective of change in participant
rather than change in implementation processes.
Sampling and Recruitment
ACOs and CPs will be notified by MassHealth that the research
team will be reaching out to invite them to participate in the
interviews. The research team will then send a standardized
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TABLE 2 | Sample sizes for study procedures.
Years 1–2 Year 3 Year 4 Year 5
KII MassHealth Leaders N = 10 N = 10
KII ACOs (2–3 reps per ACO at 17
ACOs)
N = 34–51 N = 34–51
KII CPs (1–2 reps per CP at 27 CPs) N = 27–54 N = 27–54
KII Patients N = 30 N = 30
Provider staff survey TBD TBD
ACO site visits for case studies 4 sites 4 sites
CP site visits for case studies 4 sites 4 sites
KII - Key Informant Interview
introductory e-mail to the contact listed on the ACO’s or CP’s
Participation Plan document. The e-mail will briefly explain the
goals of the KIIs and will ask the contact to identify appropriate
key informants in their organization; the e-mail will include
an attachment with a synopsis of the study. The research team
will then contact the key informants identified by the ACO or
CP contact via e-mail to address any questions and to schedule
the interview.
A Senior Manager at MassHealth will provide the research
team with contact information for MassHealth leaders
responsible for administering the DSRIP program. These
representatives will be invited to participate in an interview via
e-mail. Sampling will aim to achieve a breadth of experience
among those administering the DSRIP program.
For interviews with MassHealth patients, MassHealth
leadership will inform contacts at the ACOs and CPs that the
research team will be reaching out to them to identify patients
who may be willing to share their experiences with changes in
healthcare related to the DSRIP program. To understand the
needs of as many patients as possible, the research team will
review the nominations and purposively recruit patients who are
most likely to have experienced changes in healthcare delivery
related to the DSRIP program due to the following conditions:
(1) medical complexity (multiple medical conditions, which
may involve multiple medications and/or high utilization of
medical care); (2) living with a disability; (3) receipt of LTSS
and/or behavioral health services through a CP; there will be an
emphasis on recruiting patients with substance use disorders
(SUD); and (4) parents of children utilizing MassHealth
(Table 3). Patients who have conditions or life situations that
place them in multiple categories (i.e., medical complexity and
raising a MassHealth pediatric patient) will be recruited based
on one of the target conditions.
Interviews
Interviews will be conducted by trained research staff using semi-
structured interview guides tailored to the interview population
(Appendix B). Interview questions were developed using the
CFIR framework as a guide and include questions pertaining to
Outer Setting, Inner Setting. The interviewer will review a study
fact sheet with the participant and answer questions prior to
beginning the interview. The interview guides for ACO and CP
TABLE 3 | Sampling strategy for patient key informant interviews.
Patient category Number of interviewees Percent
Medically complex 10 33.3%
Patients with disabilities 5 16.7%
Pediatric patients 5 16.7%
CP-BH 6 20%
CP-LTSS 4 13.3%
leadership were developed by the research team and pilot-tested
with one ACO and one CP. For the patient interviews, an external
stakeholder with extensive experience in this arena reviewed the
guides for accessibility. Interviews are expected to last ∼60–
90min and will be audio recorded and professionally transcribed.
Interview questions for ACO and CP leaders will elicit
perspectives on state actions to support delivery system
transformation and the effectiveness of these actions. The
interviews will aim to understand the factors that facilitate and
impede organizational transformation in relation to three CFIR
domains: Inner Setting, Outer Setting, and Process. For example,
ACO and CP leaders will be asked how prior experience with
other value-based payment models informed early stages of
implementation in their organization (Inner Setting) and what, if
any, factors external to the organization and the DSRIP program
they feel may have facilitated or hindered implementation
of DSRIP activities or may facilitate or hinder sustainment
(Outer Setting).
Interviews with MassHealth leaders will similarly focus on
implementation of the DSRIP program, but given their high-
level administrative roles, interview questions will also explore
implementation of the DSRIP program in the broader context
of program and policy implications for the future. Interview
methods will otherwise follow those described for ACO and
CP interviews.
Interviews with MassHealth patients and caregivers of
pediatric MassHealth patients will be conducted via telephone
and will include questions relative to Outer and Inner Settings
in the CFIR framework. To ensure patient interest, accessibility
requirements, and understanding, an initial outreach call will be
made to inform patients about the project, determine if there are
any barriers, such as language or disability, and schedule a time to
conduct the interview. Efforts will be made to involve translation
services or to accommodate other needs as they arise. Patients
will be given a $50 gift certificate as a thank you for their time
and candor.
Analysis
Interview data will be analyzed using framework analysis (28, 29)
and will focus on barriers and facilitators to implementation and
sustainment within the three CFIR domains that were the focus
of interview questions. We will first establish Interrater reliability
among coders (through a process of concurrent open coding of
an initial set of interviews, comparison of coding approaches,
and refinement of code definitions as needed); the remaining
interviews will be coded independently by patients of the analytic
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team. Once all interview data are coded, secondary coding
(combining codes and creating sub-codes) will be performed
and analytic matrices with the final coded data created to
facilitate across- and within-stakeholder group analysis with
respect to perceptions of state actions supporting delivery system
transformation, barriers and facilitators to care, and the overall
patient experience. Dedoose software (30) will be used tomanage,
code and analyze interview data, and calculate Cohen’s Kappa
coefficients (31) to monitor agreement among coders over time.
Case Studies
Overview
Two waves of site visits will be conducted with a subsample of
ACOs and CPs at interim and end-points of the Demonstration
to inform case studies (Table 1). The first and second wave
of site visits will aim to achieve a deeper understanding of
the specific healthcare delivery system innovations that ACOs
and CPs are implementing and the contextual factors that may
be facilitating or impeding implementation of DSRIP-funded
activities and programs (32). The second wave of site visits will
also seek to achieve a thorough understanding of facilitators and
impediments to sustainability of the ACO and CP models after
the end of the DSRIP program.
ACO and CP Sampling
In the first wave of site visits, the research team will examine up
to four ACOs and four CPs that have achieved different levels
of success in transforming care delivery for their MassHealth
patients. ACOs and CPs will be selected based on a combination
of: (1) their progress in implementing DSRIP-funded projects
and (2) differences in organizational structure and populations
served. The timing of the site visits will be determined by
what is learned from the other data sources with respect to the
two dimensions sampling is based upon. For instance, if the
research team is able to identify ACOs and/or CPs that excel
on implementation of the DSRIP program or are struggling by
the 2nd year of the Demonstration, each could be the subject
of a site visit. At the same time, it may take until Year 3 of
the Demonstration for such patterns to emerge. In sum, we will
conduct up to eight site visits between Year 2 and 3 of the
study (Table 1). The second wave of site visits will take place
in Year 5; up to four ACOs and four CPs that represent higher
and lower levels of performance as defined by level of change
and/or achievement related to accountability scores being used by
MassHealth to determine shared risk payments. For both waves,
the site visits will focus on the healthcare delivery transformation
activities related to DSRIP that the ACOs and CPs have initiated
and the barriers and facilitators to effective implementation,
performance, and sustainability.
Site Visit Procedures and Case Study Development
Semi-structured interviews and focus groups will be conducted
with front-line clinical team members, including providers and
staff, who are closely involved with DSRIP implementation
and who represent a range of functional roles. Participants
in site visit interviews and focus groups will differ from
participants in the KIIs, focusing on those responsible for
coordinating and delivering clinical care at the ACO and
CP practice sites. Participants will include: (1) clinical leads
(e.g., medical directors and nurse managers); (2) operational
leads (e.g., office managers); (3) heads of health information
technology (HIT)/health information exchange (HIE); (4) heads
of quality improvement; and (5) heads of support services
such as case management. In addition, we will interview
representatives of ACO governing boards, Patient and Family
Advisory Committees, and selected CPs. At CPs, interviews will
be conducted with the following functional roles: (1) clinical
leads; (2) administrative directors of CP programs; (3) heads of
Health Information Technology/Health Information Exchange.
Interview guides will cover similar topics/CFIR domains to
those used in key informant interviews with leaders, but will
explore more pragmatic aspects of implementation experienced
by front-line providers and staff, including constructs in the
Characteristics of Individuals domain.
Analysis
Analysis of semi-structured interview and focus group data will
follow the process described for KIIs to construct a case study for
each site (32). In addition, the site visit data will be triangulated
with data collected Phases 1, 2, and 4 to compare and contrast
perspectives of those in different roles within the ACO and to
explore how the site visit data confirm or conflict with related
data from other sources.
Survey of Front-Line Providers and Staff at ACOs and
CPs
To understand how a large sample of front-line providers and
staff (e.g., community health workers, social workers, MDs, DOs,
NPs, PAs, nurses) experience changes in care delivery related
to the DSRIP program, two waves of front-line provider and
staff surveys will be conducted at interim and endpoints of the
Demonstration. Surveys will aim to assess the degree to which
implemented projects and ACO/CP formation are translating
into changes in care delivery from the perspective of front-
line ACO providers and CP staff. The survey will provide
an opportunity to quantitatively measure and compare these
experiences between groups of providers, practice types, and
ACOs that differ in important characteristics.
Questionnaire Development
The questionnaire used for the survey will incorporate the
previously validated measures of perceptions of care integration
from the Provider and Staff Perceptions of Integrated Care
(PSPICs) (33) and new questions developed and pilot tested by
the research team to address specific aspects of implementation
of the DSRIP program. CFIR domains explored will include
Inner Setting (care coordination within the practice site and
with external providers and community resources); Outer
Setting (patient engagement, MassHealth policies and processes,
payment and financial incentives) and Processes (practice site
structures and processes). The questionnaire will be pilot tested
with a convenience sample of ∼10–15 ACO providers and 5–
10 CP staff with similar roles to those to be included in the
survey sample. Pilot testing will include cognitive testing and
assessments for clarity, completeness, and respondent burden.
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Sampling and Administration
The sampling frame for the ACO provider survey will include
providers practicing at group practices, community health
centers, and hospital licensed health centers participating in
the ACO program at the time the program launched (i.e.,
2018). Providers at solo physician practices, outpatient hospitals,
practice sites located outside of Massachusetts, sites with fewer
than 50 MassHealth patients, and sites with an unknown number
of MassHealth patients will be excluded. From within the
sampling frame, up to 30 practice sites per ACO (including all
sites for those with <30 sites and a random sample of practice
for ACOs more than 30 practice sites), thereby oversampling the
ACOs with fewer practice sites. The providers practicing at the
353 unique practice sites in this sample will constitute the sample
frame for the survey of ACO frontline providers.
The research team will collect provider contact information
from practice and ACO administrators. The questionnaire will
then be emailed to a random sample of eligible providers (MDs,
DOs, NPs, PAs, RNs, LPNs, and LCSWs) for each ACO. Stratified
random sampling is expected and the sampling fraction will vary
by ACO and provider type such that less prevalent characteristics
are oversampled. The contact information for CP staff will be
collected from administrators at all 27 CPs and the questionnaire
will be emailed to a random sample of staff. As with the ACOs,
stratified random sampling is expected and the sampling fraction
may vary by CP staff roles such that less prevalent roles are
oversampled. The required sample size will be determined based
on anticipated response rates and power calculations performed
prior to random selection of providers and staff.
Analysis
The results of each survey wave will be analyzed overall,
by ACO characteristics, practice site characteristics, and
by provider/staff characteristics to explore heterogeneity in
provider/staff perspectives of the ACO and CP programs.
Changes over time between wave one and wave two of the
survey will also be examined overall, by ACO characteristics,
practice site characteristics, and by provider/staff characteristics.
Findings from the survey will be used to measure provider/staff
understanding of the ACO and CP programs, their perceived
effectiveness, and the concordance of perceptions between
front-line providers/staff and their organizational leaders.
Findings will also be used to assess the relationship between
providers’ perceived experience of transformation and ACO/CP
care quality and cost performance. In addition to crude analyses,
sampling and non-response weights will be applied to obtain
estimates that are adjusted for the multi-stage sampling approach
and observed sources of non-response bias.
DISCUSSION
This will be one of the first in-depth longitudinal studies of
barriers and facilitators to implementation and sustainment
of a large scale, policy-driven, state and federal government
funded intervention that aims to improve healthcare value
for a vulnerable population of publicly-insured patients. The
patient population served by the new Medicaid ACOs in
MA is a experiences socioeconomic and racial/ethnic health
disparities and healthcare inequities that are not addressed well
in traditional models of healthcare delivery in the U.S. The
shared risk ACO model, which incentivizes increased value,
has the potential to transform healthcare delivery to better
address the complexity of social determinants of health within
the healthcare system.
The Demonstration is a natural experiment; as such, the
DSRIP-supported interventions to facilitate implementation
and sustainment of the new ACOs are taking place in
uncontrolled settings. Although this limits the capacity to directly
compare specific strategies for implementing and sustaining the
transformations each ACO and CP undertakes, it also allows for
in-depth study of the implementation in a real-world setting.
This study is expected to offer important insights into the
mechanisms of transforming healthcare delivery and finance to




The Institutional Review Board (IRB) at the investigative team’s
institution determined that the overall study did not constitute
human subjects research. Each phase of primary data collection
will be submitted for IRB review and approved protocols adhered
to. Because the investigation is part of a federally mandated
evaluation of a state-led intervention, reports of the investigation
will ultimately be made available to the public. This level of
transparency reinforces the need to ensure that all data be
reported in aggregate and ensure that any individuals will not
be identifiable.
Dissemination
Study results will be available to the public on the mass.gov
website. Results of the study will be disseminated through
multiple channels: (1) peer reviewed journal publications; (2)
presentations at national research meetings; (3) publicly available
reports to the Center for Medicare and Medicaid Services; (4)
publicly available summaries posted on the MassHealth website;
and (5) directly to key stakeholders in ACO and CP leadership.
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Frontiers in Public Health | www.frontiersin.org 6 April 2021 | Volume 9 | Article 645665
Goff et al. Reducing Disparities Through Value-Based Care
AUTHOR CONTRIBUTIONS
SG contributed to development of the protocol to study
implementation of the DSRIP program and led writing of the
manuscript. DG led development of the protocol, reviewed
the manuscript, and approved the final version. MA, AK,
and JN contributed to development of the protocol, revisions
of the manuscript, and approved the final version of the
manuscript. JH oversaw development of protocol, reviewed the
manuscript, and approved the final version of the manuscript.
All authors contributed to the article and approved the
submitted version.
FUNDING
This study was funded by the Centers for Medicare and
Medicaid Services as part of the Medicaid 1115 Waiver Program.
MassHealth, the state Medicaid administrative body, provided
feedback on the study’s design, will have access to data, and
will review all materials disseminating study results prior to
publication but does not ultimately decide on publication. SG’s
time was funded in part by an NIH Career Development Award
(K23HD080870). MA’s time was funded in part by the National
Center for Advancing Translational Sciences (TL1TR001454).
ACKNOWLEDGMENTS
The authors would like to express their appreciation to the
MassHealth Payment and Care Delivery Innovation team for its
contributions to development of this protocol and for facilitating
access to documents needed for the document review portion
of the study and to key stakeholders for all phases of the
study, including key informant interviews, case studies, and the
provider and staff survey. We would also like to thank Bittie
Behl-Chadha and Rossana Valencia for their gracious assistance
with questionnaire development.
SUPPLEMENTARY MATERIAL




1. Counte MA, Howard SW, Chang L, Aaronson W. Global advances in value-
based payment and their implications for global health management
education, development, and practice. Front Public Health. (2019)
6:379. doi: 10.3389/fpubh.2018.00379
2. McClellan M, Kent J, Beales SJ, Cohen SIA, Macdonnell M, Thoumi A,
et al. Accountable care around the world: a framework to guide reform
strategies.Health Aff Proj Hope. (2014) 33:1507–15. doi: 10.1377/hlthaff.2014.
0373
3. McClellan M, Udayakumar K, Thoumi A, Gonzalez-Smith J, Kadakia K,
Kurek N, et al. Improving care and lowering costs: evidence and lessons from
a global analysis of accountable care reforms. Health Aff. (2017) 36:1920–
7. doi: 10.1377/hlthaff.2017.0535
4. HealthPayerIntelligence. The Defining Features of Current Value-Based
Care Models. HealthPayerIntelligence (2019). Available online at: https://
healthpayerintelligence.com/news/the-defining-features-of-current-value-
based-care-models (accessed April 28, 2020).
5. Kaufman BG, Spivack BS, Stearns SC, Song PH, O’Brien EC.
Impact of accountable care organizations on utilization, care,
and outcomes: a systematic review. Med Care Res Rev. (2019)
76:255–90. doi: 10.1177/1077558717745916
6. Barnett ML, McWilliams JM. Changes in specialty care use and
leakage in Medicare accountable care organizations. Am J Manag Care.
(2018) 24:e141–9.
7. McWilliams JM, Chernew ME, Zaslavsky AM, Hamed P, Landon
BE. Delivery system integration and health care spending and
quality for Medicare beneficiaries. JAMA Intern Med. (2013)
173:1447–56. doi: 10.1001/jamainternmed.2013.6886
8. McWilliams JM, Hatfield LA, Chernew ME, Landon BE, Schwartz
AL. Early performance of accountable care organizations in
medicare. N Engl J Med. (2016) 374:2357–66. doi: 10.1056/NEJMsa16
00142
9. McWilliams JM, Hatfield LA, Landon BE, Hamed P, Chernew ME.
Medicare spending after 3 years of the medicare shared savings
program. N Engl J Med. (2018) 379:1139–49. doi: 10.1056/NEJMsa18
03388
10. McWilliams JM, Chernew ME, Landon BE, Schwartz AL. Performance
differences in year 1 of pioneer accountable care organizations. N Engl J Med.
(2015) 372:1927–36. doi: 10.1056/NEJMsa1414929
11. Anderson RE, Ayanian JZ, Zaslavsky AM,McWilliams JM. Quality of care and
racial disparities in medicare among potential ACOs. J Gen InternMed. (2014)
29:1296–304. doi: 10.1007/s11606-014-2900-3
12. Peiris D, Phipps-Taylor MC, Stachowski CA, Kao L-S, Shortell SM, Lewis
VA, et al. ACOs holding commercial contracts are larger and more
efficient than noncommercial ACOs. Health Aff Proj Hope. (2016) 35:1849–
56. doi: 10.1377/hlthaff.2016.0387
13. Wu FM, Shortell SM, Lewis VA, Colla CH, Fisher ES. Assessing
differences between early and later adopters of accountable care
organizations using taxonomic analysis. Health Serv Res. (2016)
51:2318–29. doi: 10.1111/1475-6773.12473
14. Ouayogodé MH, Colla CH, Lewis VA. Determinants of success in Shared
Savings Programs: an analysis of ACO and market characteristics. Healthc
Amst Neth. (2017) 5:53–61. doi: 10.1016/j.hjdsi.2016.08.002
15. McConnell KJ, Renfro S, Chan BKS, Meath THA, Mendelson A, Cohen
D, et al. Early performance in medicaid accountable care organizations: a
comparison of oregon and Colorado. JAMA Intern Med. (2017) 177:538–
45. doi: 10.1001/jamainternmed.2016.9098
16. Colla CH, Lewis VA, Shortell SM, Fisher ES. First national survey of ACOs
finds that physicians are playing strong leadership and ownership roles.Health
Aff Proj Hope. (2014) 33:964–71. doi: 10.1377/hlthaff.2013.1463
17. Song Z, Ji Y, Safran DG, Chernew ME. Health care spending, utilization,
and quality 8 years into global payment. N Engl J Med. (2019) 381:252–
63. doi: 10.1056/NEJMsa1813621
18. Ri R, Ma R, Cl H, Wj P, Sm K, Jt L.Medicaid Accountable Care Organizations
in Four States: Implementation and Early Impacts. Vol. 97. The Milbank
quarterly. Milbank Q. (2019). Available online at: https://pubmed.ncbi.nlm.
nih.gov/30957294/ (accessed May 20, 2020).
19. Bagwell MT, Bushy A, Ortiz J. Accountable care organization implementation
experiences and rural participation: considerations for nurses. J Nurs Adm.
(2017) 47:30–4. doi: 10.1097/NNA.0000000000000433
20. Brown M, Ofili EO, Okirie D, Pemu P, Franklin C, Suk Y, et al. Morehouse
choice accountable care organization and education system (MCACO-ES):
integrated model delivering equitable quality care. Int J Environ Res Public
Health. (2019) 16:3084. doi: 10.3390/ijerph16173084
21. Michael Quinn Patton. Developmental Evaluation: Applying Complexity
Concepts to Enhance Innovation and Use. New York, NY: Guilford
Press (2011).
22. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC.
Fostering implementation of health services research findings into practice:
Frontiers in Public Health | www.frontiersin.org 7 April 2021 | Volume 9 | Article 645665
Goff et al. Reducing Disparities Through Value-Based Care
a consolidated framework for advancing implementation science. Implement
Sci IS. (2009) 4:50. doi: 10.1186/1748-5908-4-50
23. Gold J. Accountable Care Organizations, Explained. Kaiser Health News.
(2015). Available online at: https://khn.org/news/aco-accountable-care-
organization-faq/ (accessed May 12, 2020).
24. Oberlander J. Implementing the affordable care act: the promise and
limits of health care reform. J Health Polit Policy Law. (2016) 41:803–
26. doi: 10.1215/03616878-3620953
25. Barnes AJ, Unruh L, Chukmaitov A, van Ginneken E. Accountable care
organizations in the USA: types, developments and challenges. Health Policy.
(2014) 118:1–7. doi: 10.1016/j.healthpol.2014.07.019
26. Mass.gov. Massachusetts Delivery System Reform Incentive Payment
Program. Mass.gov. (2020). Available online at: https://www.mass.gov/
info-details/massachusetts-delivery-system-reform-incentive-payment-
program (accessed May 12, 2020).
27. ma-1115-waiver-summary.pdf. The MassHealth Waiver. Available online
at: https://www.mass.gov/files/documents/2017/11/03/ma-1115-waiver-
summary.pdf (accessed May 12, 2020).
28. Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the
framework method for the analysis of qualitative data in multi-
disciplinary health research. BMC Med Res Methodol. (2013)
13:117. doi: 10.1186/1471-2288-13-117
29. Srivastava A, Thomson SB. Framework Analysis: A Qualitative Methodology
for Applied Policy Research. Report No.: ID 2760705. Rochester, NY: Social
Science Research Network (2009) Available online at: https://papers.ssrn.com/
abstract=2760705 (accessed May 27, 2020).
30. Dedoose. Version 8.0.35, Web Application for Managing, Analyzing, and
Presenting Qualitative and Mixed Method Research Data. (2018). Los Angeles,
CA: SocioCultural Research Consultants, LLC. Dedoose. Available online
at: www.dedoose.com (accessed November 2020).
31. De Vries H, Elliott MN, Kanouse DE, Teleki SS. Using pooled
kappa to summarize interrater agreement across many items.
Field Methods. (2008) 20:272–82. doi: 10.1177/1525822X083
17166
32. Yin RK.Case Study Research Design andMethods. 5th ed. ThousandOaks, CA:
Sage (2014).
33. Derrett S, Gunter KE, Samaranayaka A, Singer SJ, Nocon RS, Quinn MT, et al.
Development and testing of the provider and staff perceptions of integrated
care (PSPIC) survey. Med Care Res Rev. (2017) 76:807–29. doi: 10.5334/ijic.
3236
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
The reviewer DR declared a shared affiliation, with no collaboration,
with one of the authors, DG to the handling editor at the time of
the Review.
Copyright © 2021 Goff, Gurewich, Alcusky, Kachoria, Nicholson and Himmelstein.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Public Health | www.frontiersin.org 8 April 2021 | Volume 9 | Article 645665
